White matter hyperintensities combined with serum NLRP3 in diagnosis of cognitive impairment in patients with cerebral small vessel disease

The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases

(2023) Wenfang He et al.   MOLECULAR NEUROBIOLOGY

Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis

(2023) Hua Zhu et al.   CNS Neuroscience & Therapeutics

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment

(2022) Mana Shams et al.   Frontiers in Aging Neuroscience

Biomarkers involved in the pathogenesis of cerebral small-vessel disease

(2022) Xiaolu Liu et al.   Frontiers in Neurology

Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management

(2021) Maria Clara Zanon Zotin et al.   CURRENT OPINION IN NEUROLOGY

Inflammaging and neurodegenerative diseases: Role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease

(2021) Stefania Cicolari et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Associations Between White Matter Hyperintensity Burden, Cerebral Blood Flow and Transit Time in Small Vessel Disease: An Updated Meta-Analysis

(2021) Catriona R. Stewart et al.   Frontiers in Neurology

NLRP3 inflammasome activation and cell death

(2021) Yi Huang et al.   Cellular & Molecular Immunology

NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease

(2021) Mariana Van Zeller et al.   JOURNAL OF ALZHEIMERS DISEASE

Chronic colitis exacerbates NLRP3-dependent neuroinflammation and cognitive impairment in middle-aged brain

(2021) Xiao-fei He et al.   Journal of Neuroinflammation

Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia/Macrophage Pyroptosis through NF-κB Suppression and NLRP3 Inflammasome Inhibition

(2021) Yuanyuan Ran et al.   Oxidative Medicine and Cellular Longevity

Lysophosphatidylcholine induces apoptosis and inflammatory damage in brain microvascular endothelial cells via GPR4-mediated NLRP3 inflammasome activation

(2021) Tao Liu et al.   TOXICOLOGY IN VITRO

Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease

(2021) Tingting Wang et al.   Frontiers in Immunology

White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study

(2020) Yiwei Xia et al.   Aging-US

White matter hyperintensity burden in acute stroke patients differs by ischemic stroke subtype

(2020) Anne-Katrin Giese et al.   NEUROLOGY

White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies

(2020) He-Ying Hu et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease

(2020) Niklas Lonnemann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats

(2019) Tao Jiang et al.   MOLECULAR MEDICINE

Extracellular ASC exacerbated the recurrent ischemic stroke in an NLRP3-dependent manner

(2019) Xiao-fei He et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Blood–brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging

(2018) C. Eleana Zhang et al.   Brain Imaging and Behavior

Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment

(2018) Pei-Yuan Lyu et al.   CHINESE MEDICAL JOURNAL

Cerebral Small Vessel Disease

(2018) Qian Li et al.   CELL TRANSPLANTATION

Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy

(2018) Esther M. C. van Leijsen et al.   HIPPOCAMPUS

Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)

(2018) Chongyang Ma et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline

(2015) Leif Østergaard et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease

(2013) M. Duering et al.   BRAIN